Moderna Inc. buy Royal Bank of Canada
Start price
28.03.24
/
50%
€98.67
Target price
28.03.25
€115.68
Performance (%)
2.24%
Price
26.04.24
€100.88
Summary
This prediction is currently active. With a performance of 2.24%, the BUY prediction by Royal_Bank_of_Canada for Moderna Inc. is trending in the right direction. This prediction currently runs until 28.03.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w |
|---|---|
| Moderna Inc. | 5.989% |
| iShares Core DAX® | 2.594% |
| iShares Nasdaq 100 | 3.553% |
| iShares Nikkei 225® | 0.687% |
| iShares S&P 500 | 2.209% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $125.00 price target on the stock.
Ratings data for MRNA provided by MarketBeat